Oliver Cornely
机构: University of Cologne
每年引用次数
引用次数
引用: 54,505
H-指数: 114
I10-指数 : 481
出版物: 1,110
Fungiscope – a Global Registry for Rare Fungal Infections
Maria Rüping , Jörg Vehreschild , Claudia Beisel , Carsten Müller
International Journal of Infectious Diseases 12
1
2008
Antifungal prophylaxis in neutropenic patients
A J Ullmann , M Karthaus , O A Cornely
Wiener Medizinische Wochenschrift 151 73 -79
2
2001
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
D Stippel , D Buchheidt , A Hamprecht , M Hallek
Eurosurveillance 17 ( 36) 20262 -20262
34
2012
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations.
E Csernok , H Schultz , W L Gross , F Moosig
Clinical and Experimental Rheumatology 21 ( 6)
15
2003
Antifungal susceptibility profiles of rare ascomycetous yeasts.
Antonio Pérez-Hansen , Cornelia Lass-Flörl , Michaela Lackner ,
Journal of Antimicrobial Chemotherapy 74 ( 9) 2649 -2656
9
2019
Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation.
H Lövenich , H Schütt-Gerowitt , C Keulertz , D Waldschmidt
Bone Marrow Transplantation 35 ( 10) 997 -1001
7
2005
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
Cordonnier C Maertens J , Marchetti O , Herbrecht R , Cornely OA
Bone Marrow Transplantation 46 ( 5) 709 -718
408
2011
Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi
P Bacher , O Kniemeyer , A Schönbrunn , B Sawitzki
Mucosal Immunology 7 ( 4) 916 -928
80
2014
Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation
F Farowski , V Bücker , J J Vehreschild , L Biehl
Bone Marrow Transplantation 53 ( 1) 52 -57
10
2018
Lack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections.
O A Cornely , A J Ullmann
Clinical Pharmacology & Therapeutics 89 ( 3) 351 -352
41
2011
侵襲性カンジダ症またはカンジダ血症患者の生存と治療成功に関する非薬剤性ファクター--2つのミカファンギンに関する大規模前向き研究のメタアナリシス (学会聴講記 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapyならびに46th Annual Meeting of the Infectious Diseases Society of America(2008年10月25日〜28日)ワシントンD.C.,米国)
O. A. Cornely
深在性真菌症 5 ( 1) 46 -48
2009
Use of whole-genome sequencing to investigate the epidemiology of vancomycin-resistant enterococci on an intensive care unit
Mark J. Pallen , D. Tacke , P. G. Higgins , M. J. G. T. Vehreschild
ECCMID
2014
Frequently asked questions relating to the possible infection risk of mould exposures. Answers to a round table at the workshop "Mould and serious underlying diseases; what is the risk associated with them?" at the annual conference 2009 of the German Society for Hygiene, Environmental and Preventative Medicine.
T. Gabrio , W. J. Heinz , O. A. Cornely , R. Szewzyk
Umweltmedizin in Forschung und Praxis 15 ( 2) 104 -110
2010
Importance of primary antifungal prophylaxis for hematological patients
M. Sieniawski , J. Bohlius , O. A. Cornely
Nowotwory 54 ( 3) 281 -281
2004
Candida reactive T cells for diagnosis of invasive Candida infection
Felix Carlo Köhler , OA Cornely , H Wisplinghoff , A Schauss
Mycoses
1
2017
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole
S. M. Heimann , O. A. Cornely , H. Wisplinghoff , M. Kochanek
European Journal of Clinical Microbiology & Infectious Diseases 34 ( 2) 331 -338
18
2015
Long-Term Outcome and Quality of Care of Patients with Staphylococcus aureus Bacteremia
G. F�tkenheuer , M. Preuss , B. Salzberger , N. Schmei�er
European Journal of Clinical Microbiology & Infectious Diseases 23 ( 3) 157 -162
61
2004
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials
D. L. Horn , L. Ostrosky-Zeichner , M. I. Morris , A. J. Ullmann
European Journal of Clinical Microbiology & Infectious Diseases 29 ( 2) 223 -229
54
2010
Infectious diseases publications in leading medical journals--a comparative analysis.
G. Fätkenheuer , F. Roer , B. Hirschel , O. A. Cornely
European Journal of Clinical Microbiology & Infectious Diseases 31 ( 10) 2585 -2591
2
2012
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study
G. Maschmeyer , , W. J. Heinz , B. Hertenstein
European Journal of Clinical Microbiology & Infectious Diseases 32 ( 5) 679 -689
17
2013
Jörg Janne Vehreschild PD Dr. Philipp Koehler Martin Hoenigl Cornelia Lass-Flörl Hilmar Wisplinghoff Raoul Herbrecht Andreas Groll Matteo Bassetti Michael Hallek Jacques F. Meis, MD Luis Ostrosky-Zeichner George R Thompson Maiken Cavling Arendrup Marie von Lilienfeld-Toal Jose Vazquez J. P. donnelly Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), FACP, FIDSA, FECMM, FAAM, FAAAS peter pappas Murat Akova Olaf Penack